| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_718e4c64101aa08bf54bd9cea1d3e2d5
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_8069b5e5cf8530df96a36797008a4f06 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K2319-00 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-522
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07K14-5421
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-1709 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K4-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K2-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K14-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-70
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K7-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12P21-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K5-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-04
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07H21-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K16-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07K1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C08H1-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-68 |
| filingDate |
2006-05-25-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2d6a9ee72980e6430991f8dd3872da13 |
| publicationDate |
2006-11-30-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
WO-2006128027-A1 |
| titleOfInvention |
Functionally active recombinant peptides, methods for producing same and interactions with other peptides |
| abstract |
A method is disclosed for inhibiting angiogenic activity by interacting anginex with the peptide galectin-1. Also disclosed is a method for constructing an artificial gene encoding the biologically exogenous peptide anginex and producing the protein recombinantly. The recombinant anginex protein is active at inhibiting endothelial cell growth and migration as well as inhibiting angiogenesis. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1988915-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2009043104-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-2468294-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2021123506-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8309351-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/US-8227419-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/AU-2008307145-B2
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108330137-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/WO-2020002765-A1
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-108330137-B
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/EP-1988915-A4 |
| priorityDate |
2005-05-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |